Order Article Reprints

Kamal MA, Siddiqui I, Belgiovine C, Barbagallo M, Paleari V, Pistillo D, Chiabrando C, Schiarea S, Bottazzi B, Leone R, et al. Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomarkers for the Early Diagnosis of Pancreatic Cancer. Cancers. 2022; 14(11):2653. https://doi.org/10.3390/cancers14112653

Kamal, Mohammad Azhar, Imran Siddiqui, Cristina Belgiovine, Marialuisa Barbagallo, Valentina Paleari, Daniela Pistillo, Chiara Chiabrando, Silvia Schiarea, Barbara Bottazzi, Roberto Leone, and et al. 2022. "Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomarkers for the Early Diagnosis of Pancreatic Cancer" Cancers 14, no. 11: 2653. https://doi.org/10.3390/cancers14112653

Kamal, M. A., Siddiqui, I., Belgiovine, C., Barbagallo, M., Paleari, V., Pistillo, D., Chiabrando, C., Schiarea, S., Bottazzi, B., Leone, R., Avigni, R., Migliore, R., Spaggiari, P., Gavazzi, F., Capretti, G., Marchesi, F., Mantovani, A., Zerbi, A., & Allavena, P. (2022). Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomarkers for the Early Diagnosis of Pancreatic Cancer. Cancers, 14(11), 2653. https://doi.org/10.3390/cancers14112653